Cryptococcal peritonitis in patients on the liver transplant waitlist: Reporting two cases with opposite outcomes.
Ana Caroline Ferreira da SilvaMarlone Cunha-SilvaDaniel Ferraz MazoMauy Frujuello ManaRosival Vicente de PaulaElaine Cristina de AtaídeIlka de Fátima Santana Ferreira BoinRaquel Silveira Bello StucchiTiago Sevá-PereiraPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
Cryptococcus neoformans is rarely associated with peritonitis in cirrhotic patients; nevertheless, it has a high mortality rate. Early diagnosis and prompt treatment may be the determining prognostic factors. This is a report of two patients awaiting a liver transplant who had opposite outcomes after the diagnosis of spontaneous cryptococcal peritonitis. In Patient 1, the fungal culture was positive in the blood and ascites. She had a poor evolution and died, which was likely caused by the delayed diagnosis and concomitant bacterial infections. In Patient 2, the fungus was found in the ascites, urine, and cerebrospinal fluid cultures. Antifungal treatment was effective. He underwent a liver transplant on the 83rd day of antifungal therapy and is still alive 1 year later. It is important to suspect fungal etiology when there is a lack of response to antibiotics in patients with decompensated cirrhosis and spontaneous peritonitis, and physicians must be aware of leukocyte count in the ascitic fluid, which is not so high in these cases. This report also emphasizes the need for the routine use of blood culture bottles for microbiological analysis of the ascitic fluid, as it was helpful to diagnose fungal peritonitis in both cases.
Keyphrases
- prognostic factors
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- heart failure
- type diabetes
- case report
- stem cells
- primary care
- candida albicans
- cardiovascular events
- coronary artery disease
- peripheral blood
- cardiovascular disease
- patient reported outcomes
- clinical practice
- combination therapy
- risk factors